Home
For investors
Home
For investors
More
  • Home
  • For investors
  • Sign In

  • My Account
  • Signed in as:

  • filler@godaddy.com


  • My Account
  • Sign out

Signed in as:

filler@godaddy.com

  • Home
  • For investors

Account

  • My Account
  • Sign out

  • Sign In
  • My Account

By accessing this page, you confirm that you are an accredited investor.

Maman is developing a next-generation alternative to repeated self-injections built on proprietary microneedle technologies engineered for precision drug delivery and real-time hormonal monitoring. 

Join Our Round

Why Invest Now

Why This Market

Why Invest Now

Inflection Point

  • FDA engaged 
  • Manufacturing readiness underway
  • Clinical readiness underway
  • Last round before valuation increase

Why This Team

Why This Market

Why Invest Now

Proven Builders

  • PhD Materials Science founder 
  • Lived fertility experience 
  • Medtech startup experience 
  • Scrappy & resilient operators

Why This Market

Why This Market

Why This Market

Massive Need

  • High-value growing market
  • Private-pay market 
  • High willingness to adopt
  • Clinics compete on user experience

Defensible IP

Traction & Validation

Why This Market

Protected Moat

  • 3 patent families 
  • 5 US/CAD filings 
  • Brand trademark approved 
  • Device + platform moat

Traction & Validation

Traction & Validation

Traction & Validation

Market Validation

  • $500K+ non-dilutive funding 
  • 15+ pitch competition finalist 
  • Strategic angels invested 
  • Clinical engagement underway

Partnerships & Scale

Traction & Validation

Traction & Validation

Scale Network

  • mHUB Chicago residency 
  • Megalabs regulatory support 
  • Clinical advisors 
  • Manufacturing network access

Investor One-Pager

Download PDF

Round Details

  • Raising: $500K Pre-Seed (Tranche 1 now open) 
    • Convertible Note, 20% discount, 7M post-money value cap, 6% interest
  • Use of funds: Secure Investigational Trial Approval (ITA) for Clinical Testing 
    • Pilot manufacturing 
    • Biocompatibility validation
    • Sterilization validation
  • Timeline: 
    • ITA -> Q3 2026
    • Clinical Trials -> Q1 2027
    • Regulatory Submission -> H2 2027
    • Port in market -> 2028

Join our round

Copyright © 2026 Maman Biomedical Inc. - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept